Breast cancer cases rising at an alarming rate is a matter of concern for Indians. In 2018 alone, the number of people died of breast cancer crossed 87,000. It sounds scary, but health tech startups like Niramai brings a solution to this. Niramai has introduced Thermalytix, an AI-based cancer diagnostics tool. A revolutionary innovation in the field of breast cancer diagnosis. it helps in the early detection of cancer.
Effective than mammography
While it was known that late detection is a key contributor to mortality rate among breast cancer affected, there were no effective measures for early detection available. Breast cancer is the second most common cancer after lung cancer. Indian health tech startup, Niramai’s discovery is becoming a substitute for technology which detects cancer only after tumors appear. Thermalytix, a software tool, which is more accurate than self-diagnosis and mammography. Thermalytix offers best protection from breast cancer, which is tend to affect women the most.
Birth of Niramai
Niramai was born when Dr Geetha Manjunath, an expert in AI, ML and data analytics collaborated with Nidhi Mathur, an MBA graduate from IIM Bangalore. The company was founded in July 2016. A group of researchers and engineers who detect breast cancer with the help of AI technology is there to help them. Niramai COO Nidhi Mathur claims that Thermalytix can detect lumps which are even one-fifth of the ones that can be detected through Mammography. Niramai’s breast cancer detection equipment is economically viable and can be used anywhere. This device can be used to detect cancer even for people below the age of 40.
Support from Gates foundation
Since Thermalytix check-up is radiation-free, repeat use will not bring any harm. It is more accurate than Mammography. The Bill and Melinda Gates Foundation had funded for Niramai considering its outstanding contributions to the healthcare sector.
